我们于1994年6月至9月,应用法国博福—益普生制药集团生产的思密达治疗小儿急性肠炎162例,现报告如下。 1 资料与方法 1.1 对象小儿急性肠炎162例,男90例,女72例,平均年龄9 1/2月,最大2岁,最小12d。均系急性起病,腹泻病程在7d以内,每天腹泻次数≥4次,大便性状为水样,粘液或脓血便。根据大便性状及大便镜检白细胞>5只/HP或大便培养阳性,临床诊断为细菌性肠 We in June 1994 to September, the application of France Benevolence - Ipson Pharmaceutical Group produced Smectite treatment of 162 children with acute enteritis, are as follows. 1 Materials and Methods 1.1 Object 162 children with acute enteritis, 90 males and 72 females, mean age 9 1/2 months, up to 2 years old, the smallest 12d. All were acute onset, diarrhea course within 7d, the number of diarrhea every day ≥ 4 times, stool traits of water samples, mucus or pus and blood. According to stool traits and stool microscopic examination of leukocytes> 5 / HP or stool culture positive, clinical diagnosis of bacterial intestinal